Page 28 - Sanket Koul

Centre looking to expand network of stroke units, says health secy

The medtech industry is also looking for an opening in stroke care, with experts suggesting collaborations such as public-private partnerships (PPP)

US withdrawal from WHO unfortunate, but won't affect India: Health experts

This follows US President Donald Trump's signing of an executive order on Monday, announcing the country's withdrawal from the WHO

MedTech industry divided over move to stop imports of refurbished devices

Domestic manufacturers added that the order will also stop the unregulated influx of second hand medical devices which could have been detrimental to the patient safety in India

CDSCO to disallow import of pre-owned, refurbished med devices into India

Health Ministry to constitute expert committee, import suspended until policy framework is finalised

Medtech sector seeks standard GST rate, export incentives in Budget

The scheme aims to refund to exporters the embedded central, state, and local duties and taxes paid on inputs that were so far not refunded or rebated

Odisha joins Ayushman Bharat-PMJAY scheme, signs MoU with Centre

The Centre's flagship health scheme will run in convergence with the state's Gopabandhu Jan Arogya Yojana (GJAY)

Small, medium-sized pharma firms gear up to comply with revised Schedule M

Pharma groups had wanted two year extension, will raise concerns with govt

Medtech industry expects regulatory body to reclassify more medical devices

CDSCO to initiate workshops; industry says step will bring regulatory uniformity

'A milestone': PM Narendra Modi unveils genome data of 10K Indians

Genome sequencing, a laboratory technique used to decode the entire genetic composition of an organism or cell type, lies at the heart of the project

US pharma major Eli Lilly to establish second Indian GCC in Hyderabad

Company plans to employ 1,000-1,500 skilled professionals; GCC to focus on automation, AI

HMPV scare: Centre asks states to enhance surveillance, create awareness

Seven HMPV cases detected in India; health secretary says country prepared for any potential surge in respiratory illness cases

HMPV outbreak: India reports 5 cases, govt says there's no need to panic

Health Min says current data shows no unusual surge in influenza-like respiratory illnesses

No unusual rise in flu-like cases in India, says govt amid China HMPV surge

Health Ministry convenes monitoring group meeting over hMPV surge in China

MSME Pharma units get breather as govt extends Schedule M deadline

Pharma cos with turnover of Rs 250 cr or less can submit an application to the central drugs regulator for one one-year extension

Budget wishlist: Pharma firms seek simplified taxes, stronger PLI scheme

Among other demands is the removal of Section 194R related to marketing samples that would ease business operations

No cause for alarm: Indian health officials on hMPV spread in China

The National Centre for Disease Control (NCDC) is also monitoring respiratory and seasonal influenza cases, official sources told news agency ANI

CDSCO, WB drugs body seize spurious drugs worth Rs 6.6 Cr in Kolkata

Anti-cancer, anti-diabetic drugs, labelled as manufactured in various countries, among those recovered without any supporting documents

Budget: Experts push for higher health, edu fund, duty cuts on cancer care

A key demand discussed in the meeting was the reduction of customs duty and other levies on the import of radiation machines used to treat cancer

Mankind Pharma inks pact with Innovent for immunotherapy drug in India

Drug used to treat non-small cell lung cancer, liver cancer, gastric cancer, esophageal cancer, endometrial cancer and Hodgkin's lymphoma will be priced competitively

CDSCO flags 2 drugs as spurious, another 111 fail quality test in Nov '24

While the CDSCO alert has named the brands for which they found spurious samples, the alert, however, does not name the drugmakers